Colorado BioScience Association (CBSA) welcomes FDA’s Dr. Jeffrey Shuren via video conference to today’s annual Medical Device Symposium, to be held at the Westin in Westminster.
Shuren will address attendees during an afternoon keynote and take questions from the audience. His presentation offers life sciences leaders from Colorado an opportunity to hear about trends and challenges directly from the FDA leader responsible for medical devices.
Jennifer Jones Paton, President & CEO of Colorado BioScience Association, says:
“We’re honored to welcome Dr. Shuren to CBSA’s Medical Device Symposium. His commitment to joining us for a live keynote from FDA demonstrates the importance of Colorado’s medical device community. Medical devices from Colorado make a global impact, they save and change lives around the world.”
The symposium gives Colorado medical device leaders the opportunity to network and discuss trends impacting medtech. Sessions include a special focus on regulatory milestones and an update on federal policy.
Presenters:
- Dr Jeffrey Shuren, M.D., J.D., Director of CDRH at FDA
- Fielding Greaves, Government Affairs, AdvaMed
- EY, Pulse of the Industry MedTech Report
Panelists discussing recent regulatory affairs milestones:
- Bryan McMahon, MS, RAC, Associate Director, Clinical Affairs, Zimmer Biomet
- Nam Trinh, Vice President of Supply Chain and Compliance, Securisyn Medical
- Kim Torluemke, VP, Quality & Regulatory, 3D Systems
- Dan Wittenberg, Partner, Snell & Wilmer, Moderator
Sponsors:
- Presenting sponsor – Snell & Wilmer
- Co-Sponsor – EY
- Sustaining Sponsor – Fitzsimons Innovation Community
The event begins at 1:00 p.m. at the Westin Westminster Lakehouse with registration and concludes at 5:00 p.m. with a networking reception. Onsite registration is available.
Connect with CBSA: Twitter @COBioscience, Facebook and LinkedIn
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200304005642/en/
Contacts
Sheliah Reynolds
Primavera Group for Colorado BioScience Association
(720) 289-4739
sheliah@theprimaveragroup.com
Source: Colorado BioScience Association